FDA inspection
Takeda Pharmaceutical Company Limited: FDA inspection ending Oct 24, 2003
FDA inspection 302503 · Hikari
Key facts
| Inspection ID | 302503 |
|---|---|
| Firm | Takeda Pharmaceutical Company Limited |
| FEI number | 3004664162 |
| Address | Takeda 4720, Mitsui |
| City | Hikari |
| Fiscal year | 2004 |
| Inspection end date | Oct 24, 2003 |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data